Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells

Neurobiology of Disease

Volumn 48, Issue 3, 2012, Pages 568-581

  Chidlow, Glyn ^a,b   Wood, John P M ^a,b   Ebneter, Andreas ^a,b   Casson, Robert J ^a,b  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Axonal transport; Glaucoma; Interleukin 6; Neuritogenesis; Optic nerve head; Proinflammatory cytokines; Retinal ganglion cell

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CAROTID ARTERY OBSTRUCTION; CELL DISRUPTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GLAUCOMA; IMMUNOFLUORESCENCE TEST; INTRAOCULAR HYPERTENSION; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; RAT; RETINA GANGLION CELL;

ANIMALS; AXONAL TRANSPORT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GLAUCOMA; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84865543408     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.07.026     Document Type: Article

References (77)

1. Barron M.J., Griffiths P., Turnbull D.M., Bates D., Nichols P. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br. J. Ophthalmol. 2004, 88:286-290.
2. Benowitz L., Yin Y. Rewiring the injured CNS: lessons from the optic nerve. Exp. Neurol. 2008, 209:389-398.
3. Berger S., Savitz S.I., Nijhawan S., Singh M., David J., Rosenbaum P.S., et al. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 2008, 49:3605-3610.
4. Berry M., Ahmed Z., Lorber B., Douglas M., Logan A. Regeneration of axons in the visual system. Restor. Neurol. Neurosci. 2008, 26:147-174.
5. Blaugrund E., Lavie V., Cohen I., Solomon A., Schreyer D.J., Schwartz M. Axonal regeneration is associated with glial migration: comparison between the injured optic nerves of fish and rats. J. Comp. Neurol. 1993, 330:105-112.
6. Bosco A., Steele M.R., Vetter M.L. Early microglia activation in a mouse model of chronic glaucoma. J. Comp. Neurol. 2011, 519:599-620.
7. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 2008, 28:2735-2744.
8. Burgoyne C.F., Downs J.C., Bellezza A.J., Suh J.K., Hart R.T. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog. Retin. Eye Res. 2005, 24:39-73.
9. Cafferty W.B., Gardiner N.J., Das P., Qiu J., McMahon S.B., Thompson S.W. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J. Neurosci. 2004, 24:4432-4443.
10. Cao Z., Gao Y., Bryson J.B., Hou J., Chaudhry N., Siddiq M., et al. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J. Neurosci. 2006, 26:5565-5573.
11. Chidlow G., Wood J.P., Casson R.J. Pharmacological neuroprotection for glaucoma. Drugs 2007, 67:725-759.
12. Chidlow G., Wood J.P., Manavis J., Osborne N.N., Casson R.J. Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest. Ophthalmol. Vis. Sci. 2008, 49:762-771.
13. Chidlow G., Wood J.P., Sarvestani G., Manavis J., Casson R.J. Evaluation of Fluoro-Jade C as a marker of degenerating neurons in the rat retina and optic nerve. Exp. Eye Res. 2009, 88:426-437.
14. Chidlow G., Holman M.C., Wood J.P., Casson R.J. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat. Invest. Ophthalmol. Vis. Sci. 2010, 51:1483-1497.
15. Chidlow G., Daymon M., Wood J.P., Casson R.J. Localization of a wide-ranging panel of antigens in the rat retina by immunohistochemistry: comparison of Davidson's solution and formalin as fixatives. J. Histochem. Cytochem. 2011, 59:884-898.
16. Chidlow G., Ebneter A., Wood J.P., Casson R.J. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 2011, 121:737-751.
17. Deng Y.Y., Lu J., Ling E.A., Kaur C. Role of microglia in the process of inflammation in the hypoxic developing brain. Front. Biosci. (Schol. Ed.) 2011, 3:884-900.
18. Doster S.K., Lozano A.M., Aguayo A.J., Willard M.B. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron 1991, 6:635-647.
19. Ebneter A., Casson R.J., Wood J.P., Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest. Ophthalmol. Vis. Sci. 2010, 51:6448-6460.
20. Esposito E., Cuzzocrea S. Anti-TNF therapy in the injured spinal cord. Trends Pharmacol. Sci. 2011, 32:107-115.
21. Fechtner R.D., Weinreb R.N. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv. Ophthalmol. 1994, 39:23-42.
22. Flammer J., Orgul S., Costa V.P., Orzalesi N., Krieglstein G.K., Serra L.M., et al. The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 2002, 21:359-393.
23. Fritschy J.M. Is my antibody-staining specific? How to deal with pitfalls of immunohistochemistry. Eur. J. Neurosci. 2008, 28:2365-2370.
24. Hakkoum D., Stoppini L., Muller D. Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J. Neurochem. 2007, 100:747-757.
25. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
26. Hans V.H., Kossmann T., Lenzlinger P.M., Probstmeier R., Imhof H.G., Trentz O., et al. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J. Cereb. Blood Flow Metab. 1999, 19:184-194.
27. Hernandez M.R., Miao H., Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog. Brain Res. 2008, 173:353-373.
28. Honjo M., Tanihara H., Kido N., Inatani M., Okazaki K., Honda Y. Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA- and kainic acid-induced neuronal death. Invest. Ophthalmol. Vis. Sci. 2000, 41:552-560.
29. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 2007, 179:1523-1537.
30. Ito Y., Yamamoto M., Li M., Doyu M., Tanaka F., Mutch T., et al. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves. Brain Res. 1998, 793:321-327.
31. Jakobs T.C., Libby R.T., Ben Y., John S.W., Masland R.H. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell Biol. 2005, 171:313-325.
32. Johnson E.C., Morrison J.C. Friend or foe? Resolving the impact of glial responses in glaucoma. J. Glaucoma 2009, 18:341-353.
33. Johnson E.C., Jia L., Cepurna W.O., Doser T.A., Morrison J.C. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2007, 48:3161-3177.
34. Johnson E.C., Doser T.A., Cepurna W.O., Dyck J.A., Jia L., Guo Y., et al. Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest. Ophthalmol. Vis. Sci. 2011, 52:504-518.
35. Ju W.K., Lee M.Y., Hofmann H.D., Kirsch M., Chun M.H. Expression of CNTF in Muller cells of the rat retina after pressure-induced ischemia. Neuroreport 1999, 10:419-422.
36. Kaur K., Sharma A.K., Singal P.K. Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H106-H113.
37. Kitaoka Y., Kwong J.M., Ross-Cisneros F.N., Wang J., Tsai R.K., Sadun A.A., et al. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest. Ophthalmol. Vis. Sci. 2006, 47:1448-1457.
38. Leon S., Yin Y., Nguyen J., Irwin N., Benowitz L.I. Lens injury stimulates axon regeneration in the mature rat optic nerve. J. Neurosci. 2000, 20:4615-4626.
39. Levkovitch-Verbin H., Quigley H.A., Martin K.R., Valenta D., Baumrind L.A., Pease M.E. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest. Ophthalmol. Vis. Sci. 2002, 43:402-410.
40. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
41. Lorber B., Guidi A., Fawcett J.W., Martin K.R. Activated retinal glia mediated axon regeneration in experimental glaucoma. Neurobiol. Dis. 2012, 45:243-252.
42. Lull M.E., Block M.L. Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010, 7:354-365.
43. Martin K.R., Quigley H.A., Valenta D., Kielczewski J., Pease M.E. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp. Eye Res. 2006, 83:255-262.
44. Mertsch K., Hanisch U.K., Kettenmann H., Schnitzer J. Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system. J. Comp. Neurol. 2001, 431:217-227.
45. Morin P.J., Abraham C.R., Amaratunga A., Johnson R.J., Huber G., Sandell J.H., et al. Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized. J. Neurochem. 1993, 61:464-473.
46. Murphy P.G., Grondin J., Altares M., Richardson P.M. Induction of interleukin-6 in axotomized sensory neurons. J. Neurosci. 1995, 15:5130-5138.
47. Murphy P.G., Borthwick L.S., Johnston R.S., Kuchel G., Richardson P.M. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J. Neurosci. 1999, 19:3791-3800.
48. Nakazawa T., Nakazawa C., Matsubara A., Noda K., Hisatomi T., She H., et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 2006, 26:12633-12641.
49. Nakazawa T., Takahashi H., Nishijima K., Shimura M., Fuse N., Tamai M., et al. Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. J. Neurochem. 2007, 100:1018-1031.
50. Pang I.H., Zeng H., Fleenor D.L., Clark A.F. Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci. 2007, 8:11.
51. Perrin F.E., Lacroix S., Aviles-Trigueros M., David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 2005, 128:854-866.
52. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
53. Pool M., Thiemann J., Bar-Or A., Fournier A.E. NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth. J. Neurosci. Methods 2008, 168:134-139.
54. Quigley H.A. Neuronal death in glaucoma. Prog. Retin. Eye Res. 1999, 18:39-57.
55. Quigley H.A. Glaucoma. Lancet 2011, 377:1366-1377.
56. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
57. Rhodes K.J., Trimmer J.S. Antibodies as valuable neuroscience research tools versus reagents of mass distraction. J. Neurosci. 2006, 26:8017-8020.
58. Rioja I., Bush K.A., Buckton J.B., Dickson M.C., Life P.F. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin. Exp. Immunol. 2004, 137:65-73.
59. Sairanen T.R., Lindsberg P.J., Brenner M., Siren A.L. Global forebrain ischemia results in differential cellular expression of interleukin-1beta (IL-1beta) and its receptor at mRNA and protein level. J. Cereb. Blood Flow Metab. 1997, 17:1107-1120.
60. Salinas-Navarro M., Alarcon-Martinez L., Valiente-Soriano F.J., Jimenez-Lopez M., Mayor-Torroglosa S., Aviles-Trigueros M., et al. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration. Exp. Eye Res. 2010, 90:168-183.
61. Sanchez R.N., Chan C.K., Garg S., Kwong J.M., Wong M.J., Sadun A.A., et al. Interleukin-6 in retinal ischemia reperfusion injury in rats. Invest. Ophthalmol. Vis. Sci. 2003, 44:4006-4011.
62. Saper C.B. An open letter to our readers on the use of antibodies. J. Comp. Neurol. 2005, 493:477-478.
63. Sappington R.M., Calkins D.J. Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure. Invest. Ophthalmol. Vis. Sci. 2008, 49:3004-3017.
64. Sappington R.M., Chan M., Calkins D.J. Interleukin-6 protects retinal ganglion cells from pressure-induced death. Invest. Ophthalmol. Vis. Sci. 2006, 47:2932-2942.
65. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813:878-888.
66. Schindler R., Clark B.D., Dinarello C.A. Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. J. Biol. Chem. 1990, 265:10232-10237.
67. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 2002, 22:3052-3060.
68. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., et al. Interleukin-6, a mental cytokine. Brain Res. Rev. 2011, 67:157-183.
69. Streit W.J., Hurley S.D., McGraw T.S., Semple-Rowland S.L. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J. Neurosci. Res. 2000, 61:10-20.
70. Suzuki S., Tanaka K., Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow Metab. 2009, 29:464-479.
71. Tomimoto H., Ihara M., Wakita H., Ohtani R., Lin J.X., Akiguchi I., et al. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol. 2003, 106:527-534.
72. Tsakiri N., Kimber I., Rothwell N.J., Pinteaux E. Mechanisms of interleukin-6 synthesis and release induced by interleukin-1 and cell depolarisation in neurones. Mol. Cell. Neurosci. 2008, 37:110-118.
73. Vidal-Sanz M., Salinas-Navarro M., Nadal-Nicolas F.M., Alarcon-Martinez L., Valiente-Soriano F.J., Miralles de Imperial J., et al. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog. Retin. Eye Res. 2011.
74. Wen R., Tao W., Li Y., Sieving P.A. CNTF and retina. Prog. Retin. Eye Res. 2012, 31:136-151.
75. Yanagi M., Kawasaki R., Wang J.J., Wong T.Y., Crowston J., Kiuchi Y. Vascular risk factors in glaucoma: a review. Clin. Experiment. Ophthalmol. 2011, 39:252-258.
76. Yuan L., Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000, 32:42-50.
77. Yuan L., Neufeld A.H. Activated microglia in the human glaucomatous optic nerve head. J. Neurosci. Res. 2001, 64:523-532.